Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
3.600
-0.200 (-5.26%)
Apr 28, 2026, 4:00 PM EDT - Market closed
LIXT Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 5.11 | 1.04 | 4.2 | 5.35 | 4.82 | Upgrade
|
| Cash & Short-Term Investments | 5.11 | 1.04 | 4.2 | 5.35 | 4.82 | Upgrade
|
| Cash Growth | 391.54% | -75.28% | -21.48% | 10.98% | -4.84% | Upgrade
|
| Prepaid Expenses | 0.07 | 0.11 | 0.03 | 0.06 | 0.12 | Upgrade
|
| Other Current Assets | - | - | 0.08 | 0.15 | 0.15 | Upgrade
|
| Total Current Assets | 5.18 | 1.15 | 4.31 | 5.56 | 5.09 | Upgrade
|
| Property, Plant & Equipment | 7.56 | - | - | - | - | Upgrade
|
| Total Assets | 12.73 | 1.15 | 4.31 | 5.56 | 5.09 | Upgrade
|
| Accounts Payable | 0.31 | 0.06 | 0.12 | 0.18 | 0.19 | Upgrade
|
| Accrued Expenses | 0.13 | 0.03 | 0.04 | 0.05 | 0.03 | Upgrade
|
| Current Portion of Leases | 0.6 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 0.3 | 0.24 | 0.16 | 0.17 | 0.08 | Upgrade
|
| Total Current Liabilities | 1.33 | 0.32 | 0.31 | 0.4 | 0.3 | Upgrade
|
| Long-Term Leases | 0.44 | - | - | - | - | Upgrade
|
| Total Liabilities | 1.77 | 0.32 | 0.31 | 0.4 | 0.3 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 66.01 | 49.39 | 48.98 | 45.06 | 38.37 | Upgrade
|
| Retained Earnings | -58.08 | -52.07 | -48.48 | -43.39 | -37.08 | Upgrade
|
| Total Common Equity | 7.93 | -2.67 | 0.49 | 1.67 | 1.29 | Upgrade
|
| Minority Interest | 1.3 | - | - | - | - | Upgrade
|
| Shareholders' Equity | 10.96 | 0.83 | 3.99 | 5.17 | 4.79 | Upgrade
|
| Total Liabilities & Equity | 12.73 | 1.15 | 4.31 | 5.56 | 5.09 | Upgrade
|
| Total Debt | 1.03 | - | - | - | - | Upgrade
|
| Net Cash (Debt) | 4.07 | 1.04 | 4.2 | 5.35 | 4.82 | Upgrade
|
| Net Cash Growth | 291.98% | -75.28% | -21.48% | 10.98% | -4.84% | Upgrade
|
| Net Cash Per Share | 0.84 | 0.46 | 2.19 | 3.38 | 3.58 | Upgrade
|
| Filing Date Shares Outstanding | 11.62 | 2.68 | 2.25 | 1.67 | 1.37 | Upgrade
|
| Total Common Shares Outstanding | 8.79 | 2.25 | 2.25 | 1.66 | 1.37 | Upgrade
|
| Working Capital | 3.85 | 0.83 | 3.99 | 5.17 | 4.79 | Upgrade
|
| Book Value Per Share | 0.90 | -1.19 | 0.22 | 1.00 | 0.94 | Upgrade
|
| Tangible Book Value | 7.93 | -2.67 | 0.49 | 1.67 | 1.29 | Upgrade
|
| Tangible Book Value Per Share | 0.90 | -1.19 | 0.22 | 1.00 | 0.94 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.